SEC 13F Intelligence

First Light Asset Management, LLC / YMABUSD

First Light Asset Management, LLC’s Y-Mabs Therapeutics Inc Com Position

Does First Light Asset Management, LLC own Y-Mabs Therapeutics Inc Com (YMABUSD)? Not currently — the last reported position was 577.7K shares worth $16M in Q3 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$16M
Q3 2021
Shares
577.7K
% of Portfolio
+1.09%
Quarters Held
6
position exited

Position History YMABUSD

Reported value by quarter
Q2 ’20: $26MQ2 ’20Q3 ’20: $23MQ3 ’20Q4 ’20: $31MQ4 ’20Q1 ’21: $29MQ1 ’21Q2 ’21: $32MQ2 ’21Q3 ’21: $16MQ3 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2021577.7K$16M+1.09%
Q2 2021950.2K$32M+1.93%
Q1 2021944.3K$29M+1.89%
Q4 2020635.7K$31M+2.33%
Q3 2020608.2K$23M+2.39%
Q2 2020607.6K$26M+3.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Light Asset Management, LLC’s full portfolio or all institutional holders of YMABUSD.